Thiel, Eckhard, 1944-
Thiel, E.
Eckhard Thiel médecin allemand
Thiel, Eckhard
VIAF ID: 212755991 (Personal)
Permalink: http://viaf.org/viaf/212755991
Preferred Forms
- 100 0 _ ‡a Eckhard Thiel ‡c médecin allemand
-
-
- 100 1 _ ‡a Thiel, Eckhard
- 100 1 _ ‡a Thiel, Eckhard
-
- 100 1 _ ‡a Thiel, Eckhard ‡d 1944-
- 100 1 _ ‡a Thiel, Eckhard ‡d 1944-
- 100 1 0 ‡a Thiel, Eckhard, ‡d 1944-
-
-
-
-
4xx's: Alternate Name Forms (12)
5xx's: Related Names (4)
- 551 _ _ ‡a Berlin ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Freie Universität Berlin ‡b Fachbereich Humanmedizin ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a München ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _ ‡a Tübingen ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
Title | Sources |
---|---|
Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2 | |
Central nervous system disease in hematologic malignancies: historical perspective and practical applications | |
Clinical efficacy, tolerability, and safety of SAM486A, a novel polyamine biosynthesis inhibitor, in patients with relapsed or refractory non-Hodgkin's lymphoma: results from a phase II multicenter study | |
Comparison of T-cell receptor repertoire restriction in blood and tumor tissue of colorectal cancer patients. | |
Differential micro-RNA expression in primary CNS and nodal diffuse large B-cell lymphomas | |
Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy | |
Efficacy and pharmacologic data of second-generation tyrosine kinase inhibitor nilotinib in BCR-ABL-positive leukemia patients with central nervous system relapse after allogeneic stem cell transplantation | |
FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors | |
Genome-wide DNA-mapping of CD34+ cells from patients with myelodysplastic syndrome using 500K SNP arrays identifies significant regions of deletion and uniparental disomy | |
High correlation of the proteome patterns in bone marrow and peripheral blood blast cells in patients with acute myeloid leukemia | |
High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma | |
High expression of IGFBP2 is associated with chemoresistance in adult acute myeloid leukemia | |
Hydrops lysosomalis generalisatus--an underestimated side effect of hydroxyethyl starch therapy? | |
Ifosfamide/liposomal daunorubicin is a well tolerated and active first-line chemotherapy regimen in advanced soft tissue sarcoma: results of a phase II study | |
Immunological diagnosis of leukemias and lymphomas : international symposium of the Institut für Hämatologie, GSF, October 28-30, 1976, Neuherberg/Munich | |
Immunological monitoring of cancer vaccine therapy | |
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial | |
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer | |
Interferon bei Non-Hodgkin-Lymphomen und Plasmozytom Symposium in Berlin, 14. Dezember 1988 ; 8 Tabellen | |
Leukemia, 1984: | |
Leukemia Recent Developments in Diagnosis and Therapy | |
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation | |
Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome | |
Malignant melanoma--clinical development of peptide-based melanoma vaccines | |
Meningeal dissemination in primary CNS lymphoma: diagnosis, treatment, and survival in a large monocenter cohort | |
Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts | |
Mutation analysis of hCDC4 in AML cells identifies a new intronic polymorphism | |
Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions | |
Non-Hodgkin-Lymphome Trends in Diagnostik und Therapie | |
Pathologische Spontanaktivität im Wachen und Schlafen Kontinuierl. elektromyogr. u. elektroencephalogr. Registrierg | |
Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma | |
Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients | |
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma | |
Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia | |
Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy. | |
Rational peptide-based tumour vaccine development and T cell monitoring | |
Recent advances in cell biology of acute leukemia : impact on clinical diagnosis | |
Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation | |
Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. | |
Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic | |
Surface expression of gpA33 is dependent on culture density and cell-cycle phase and is regulated by intracellular traffic rather than gene transcription | |
Surgery for primary CNS lymphoma? Challenging a paradigm | |
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients | |
Tonarten, Spielarten, Eigenarten kreative Elemente in der Musiktherapie mit Kindern und Jugendlichen | |
Transarterial chemoembolization of liver metastases from uveal melanoma after failure of systemic therapy: toxicity and outcome | |
Transplantation of selected or transgenic blood stem cells - a future treatment for HIV/AIDS? | |
Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study | |
Treatment of primary intraocular lymphoma with oral trofosfamide: report of two cases and review of the literature | |
Treatment options for central nervous system lymphomas in immunocompetent patients | |
Viral encephalitis after allogeneic stem cell transplantation: a rare complication with distinct characteristics of different causative agents. | |
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis | |
Wilms tumor gene (WT1) expression as a panleukemic marker |